About Samrat Pharmachem
Samrat Pharmachem is a company based in Mumbai (India) founded in 1992 by Lalit Mehta. The company has 28 employees as of March 31, 2024. Samrat Pharmachem offers products and services including 3-5 Di Iodosalicylic Acid, Ammonium Iodide, Cadmium Iodide, and Calcium Iodate. Samrat Pharmachem operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Mumbai, India
- Employees 28 as on 31 Mar, 2024
- Founders Lalit Mehta
- Stage Public
-
Sectors
Chemicals & MaterialsHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Samrat Pharmachem Limited
-
Annual Revenue
$33.48 M (USD)1.52as on Mar 31, 2025
-
Net Profit
$832.46 K (USD)228.87as on Mar 31, 2025
-
EBITDA
$1.25 M (USD)278.49as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
28
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Samrat Pharmachem
Samrat Pharmachem is a publicly listed company on the BSE with ticker symbol SAMRATPH in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Samrat Pharmachem
Samrat Pharmachem offers a comprehensive portfolio of products and services, including 3-5 Di Iodosalicylic Acid, Ammonium Iodide, Cadmium Iodide, and Calcium Iodate.
Iodine derivative used in pharmaceutical applications
Compound for chemical and pharmaceutical processes
Iodine-based chemical for industrial use
Additive for food, animal feed, and pharmaceuticals
Funding Insights of Samrat Pharmachem
Detailed funding history for Samrat Pharmachem
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Samrat Pharmachem
Investment portfolio details for Samrat Pharmachem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Samrat Pharmachem
Detailed financials for Samrat Pharmachem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Samrat Pharmachem Comparisons
Peer comparison for Samrat Pharmachem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Samrat Pharmachem
Samrat Pharmachem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Samrat Pharmachem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Samrat Pharmachem
Complete news archive for Samrat Pharmachem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samrat Pharmachem
Samrat Pharmachem was founded in 1992.
Samrat Pharmachem is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Samrat Pharmachem is 28.
Annual revenue of Samrat Pharmachem is $33.48M as on Mar 31, 2025.
Samrat Pharmachem was founded in 1992 in Mumbai, India, and is involved in the production of chemical products used in pharmaceutical, food, chemical, fertilizer, and salt sectors. A portfolio of 23 products is maintained, with exports directed to international markets. Certifications such as ISO 9001:2008, NSIC DB, SMERA, and NSIC-Crisil are held by the company.
Samrat Pharmachem's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Samrat Pharmachem offers 3-5 Di Iodosalicylic Acid, Ammonium Iodide, Cadmium Iodide, and Calcium Iodate.
Yes, Samrat Pharmachem is publicly traded on BSE under the ticker symbol SAMRATPH.
The ticker symbol of Samrat Pharmachem is SAMRATPH on BSE.